CSIMarket
 
Neuronetics inc   (STIM)
Other Ticker:  
 
 
Price: $3.7900 $-0.11 -2.821%
Day's High: $3.99 Week Perf: -12.06 %
Day's Low: $ 3.76 30 Day Perf: 20.13 %
Volume (M): 86 52 Wk High: $ 4.44
Volume (M$): $ 327 52 Wk Avg: $2.26
Open: $3.94 52 Wk Low: $1.03



 Market Capitalization (Millions $) 109
 Shares Outstanding (Millions) 29
 Employees -
 Revenues (TTM) (Millions $) 71
 Net Income (TTM) (Millions $) -30
 Cash Flow (TTM) (Millions $) -11
 Capital Exp. (TTM) (Millions $) 2

Neuronetics Inc
Neuronetics Inc is a medical technology company that focuses on developing and commercializing non-invasive brain stimulation therapies for patients with psychiatric and neurological disorders. The company's flagship product is NeuroStar Advanced Therapy, which utilizes transcranial magnetic stimulation (TMS) to target specific areas of the brain involved in mood regulation.

NeuroStar Advanced Therapy is FDA-approved for the treatment of major depressive disorder (MDD) and is backed by clinical studies demonstrating its effectiveness. The procedure involves the use of a non-invasive device that delivers magnetic pulses to the brain, stimulating the nerve cells involved in mood regulation.

Neuronetics Inc is committed to providing alternative treatment options for patients who have not responded well to traditional therapies, such as medication or talk therapy. They aim to improve patients' quality of life by reducing symptoms of depression and other psychiatric disorders.

The company is based in Malvern, Pennsylvania, and collaborates with healthcare professionals, researchers, and patients to advance the understanding and adoption of TMS therapy. Neuronetics Inc is dedicated to ongoing research and development to expand the applications of TMS technology and improve patient outcomes in the field of mental health.


   Company Address: 3222 Phoenixville Pike Malvern 19355 PA
   Company Phone Number: 640-4202   Stock Exchange / Ticker: NASDAQ STIM
   


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
• View Complete Report
   



Neuronetics Inc

Neuronetics Inc. Surpasses Expectations with Impressive Revenue Growth in Fourth Quarter of 2023

Neuronetics, a commercial stage medical technology company, has recently announced its financial and operating results for the fourth quarter and full year of 2023. Despite experiencing a loss per share of $-0.17, which is an improvement compared to the loss of $-0.30 per share in the previous year, Neuronetics has shown promising growth. With an increase in revenue by 13.348% to $20.63 million from $18.20 million in the comparable quarter a year prior, the company has outperformed its competitors in the Medical Equipment & Supplies sector.
In fact, most companies in the Medical Equipment & Supplies industry saw only a 6.66% increase in their top-line during the same period. Additionally, Neuronetics reported a net shortfall of $-5.377 million, a significant improvement compared to the deficit of $-8.290 million in the comparable quarter a year ago.

Partnership

Neuronetics and Transformations Care Network Expand Access to Cutting-Edge TMS Treatment for Neurohealth Disorders

Published Thu, Mar 7 2024 1:22 PM UTC

Neuronetics Partners with Transformations Care Network to Expand Availability of NeuroStar TMS Equipment Neuronetics, a medical technology company specializing in products for neurohealth disorders, has recently announced an exclusive partnership with Transformations Care Network (TCN), one of the largest mental health care providers in the country. This partnership aims to ...

Product Service News

Neuronetics Unveils Future-Ready TrakStar Patient Data Management System, Boosting Workflow Efficiencies for NeuroStar TMS Providers

Published Mon, Feb 12 2024 1:32 PM UTC

Neuronetics, a leading medical technology company, has recently introduced the latest iteration of its TrakStar Patient Data Management System. This innovative system is poised to revolutionize the workflow efficiencies for NeuroStar Transcranial Magnetic Stimulation (TMS) providers, ensuring improved patient care and outcomes. By interpreting the articles Neuronetics Launch...

Product Service News

Augmenting Neurological Therapy: Lucet Health Eases Access to NeuroStar TMS Treatment for Depression

Published Tue, Feb 6 2024 1:28 PM UTC

The landscape of mental health treatment is changing at an unprecedented pace, and at the heart of this transformation is a big change from Lucet Health, which is set to massively improve accessibility to Transcranial Magnetic Stimulation (TMS), a pioneering neurological therapy. Lucet Health, a prominent health insurance company, has updated its policy and changed its crite...

Management Announcement

Revolutionizing Depression Treatment: NeuroStar TMS Grabs Expanded Approval, Redefining Hope in Japan }, finish_reaso

Published Mon, Dec 4 2023 1:56 PM UTC

Technological Advances Streamline and Enhance MDD Treatment: NeuroStar TMS Receives Expanded Regulatory Approval in Japan
In recent news, Neuronetics Inc. has experienced a staggering 42.96% increase in shares following the expanded regulatory approval of their groundbreaking invention, the NeuroStar TMS system, in Japan. This milestone represents a significant step forw...






 

Neuronetics Inc's Segments
 
 
• View Complete Report
  Company Estimates  
  Revenue Outlook
Neuronetics Inc does not provide revenue guidance.

Earnings Outlook
Neuronetics inc does not provide earnings estimates.

 
Geographic Revenue Dispersion




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com